Plain-English translation of NCT05398185 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing WiseApp, a smartphone application designed specifically for Spanish-speaking people living with HIV. The app works together with a special pill bottle called CleverCap that tracks when you take your medications and reminds you not to miss doses. The study wants to see if this combination helps people take their HIV medications more consistently and improve their overall health.
Many people with HIV, especially Latino communities in the northeastern United States and the Caribbean, struggle to take their medications regularly—which can lead to treatment failure and serious health complications. This trial exists to test whether this new technology can help solve that problem by making it easier to stay on track with treatment.
If you're in the intervention group, you'll receive a CleverCap smart pill bottle that dispenses your HIV medication and connects to the WiseApp on your smartphone to track your adherence. If you're in the control group, you'll receive standard health services at your clinic and a brief educational session about taking your medications. Both groups will share data about medication adherence, quality of life, and any symptoms you experience as part of the study.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
United States
Dominican Republic